Horizon Discovery Group plc announced three of the world's leading gene editing scientists have joined the company's Scientific Advisory Board (SAB). The scientists are Dr. Emmanuelle Charpentier, Dr. Keith Joung and Dr. Feng Zhang. Dr. Charpentier is currently serving as head of the Department of Regulation in Infection Biology at the Helmholtz Centre for Infection Research in Braunschweig and Hannover Medical School.

Dr. J. Keith Joung has a long history in the development and application of engineered DNA-binding domains and systems for creating customized nucleases for genome editing. Over the past ten years, his lab has pioneered methods for targeted genome editing using engineered zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), as well as CRISPR-Cas9. Dr. Feng Zhang, Ph.D., is currently serving as W.M. Keck Career Development Professor with joint appointment in Biological Engineering and also Brain and Cognitive Sciences departments at the Massachusetts Institute of Technology (MIT).